QUOTE AND NEWS
Reuters  3 hrs ago  Comment 
Novartis cannot rule out selling its Alcon eye care and surgery equipment division, its chief lawyer said on Thursday, helping fan speculation the Swiss drug company could offload...
FiercePharma  3 hrs ago  Comment 
Roche to beat Novartis, Pfizer to pharma throne by 2022 as industry passes $1T mark esagonowsky Thu, 09/15/2016 - 08:57
The Hindu Business Line  Sep 14  Comment 
Glenmark Pharmaceuticals has received final approval from the US health regulator for generic Diclofenac Sodium gel used for treatment of skin lesions.“Glenmark Pharmaceuticals Inc USA has been grant...
newratings.com  Sep 14  Comment 
14th September 2016 Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful. Novartis Finance S.A. ...
newratings.com  Sep 13  Comment 
13th September 2016 Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful. Novartis Finance S.A. ...
FierceBiotech  Sep 12  Comment 
Novartis VC fund coleads $17M Series A in inflammatory disease startup ntaylor Mon, 09/12/2016 - 07:05
newratings.com  Sep 12  Comment 
This is an update of the announcement from 09:02 13.09.2016 BST. Reason for the update: amended period of stabilisation date 13th September 2016 Not for distribution, directly or indirectly, in or into the United States or any...
Motley Fool  Sep 9  Comment 
Surprising losses, a new threat, and renewed fears yanked out some feathers last month.
The Hindu Business Line  Sep 9  Comment 
But pharma company maintains there is no shortage




 

Fuerralz? That's marvelously good to know.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki